Scandinavian Working Papers in Economics

Discussion Papers,
Statistics Norway, Research Department

No 1032: A cost-benefit assessment of covid-19 strategies. The case of Norway

Geir H. M. Bjertnæs (), Erling Holmøy and Roger Hammersland
Additional contact information
Roger Hammersland: Statistics Norway

Abstract: This study evaluates the costs and benefits of alternative COVID-19 strategies for Norway, drawing on ex-post evidence from countries that pursued markedly different approaches. We argue that an elimination strategy—combining strict infection control with stringent border measures until a vaccine becomes available—delivers the greatest net benefits when a successful vaccine is expected within a short timeframe. Under vaccine uncertainty, both elimination and mitigation, the latter allowing gradual community spread, remain viable options. Norway adopted a suppression approach based on extensive TTIQ measures. Our findings suggest that this strategy was inferior compared to both elimination and mitigation. Finally, we compare ex-post assessments of costs and benefits with those emphasized in ex-ante evaluations, highlighting key discrepancies.

Keywords: COVID-19; Strategies; Cost-benefit analysis

JEL-codes: H51; I18

40 pages, January 2026

Full text files

DP1032.pdf PDF-file 

Download statistics

Questions (including download problems) about the papers in this series should be directed to L Maasø ()
Report other problems with accessing this service to Sune Karlsson ().

RePEc:ssb:dispap:1032This page generated on 2026-04-10 04:36:13.